Michael B. Elefante’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Michael B. Elefante’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-3,000	Closed	-$161K	–	130
2014 Q3	$161K	Hold	3,000	–	–	0.07%	105
2014 Q2	$157K	Sell	3,000 -315	-10%	-$16.1K	0.07%	116
2014 Q1	$176K	Sell	3,315 -4,940	-60%	-$228K	0.08%	108
2013 Q4	$331K	Sell	8,255 -56,915	-87%	-$2.24M	0.15%	77
2013 Q3	$2.46M	Sell	65,170 -2,375	-4%	-$92.6K	1.23%	31
2013 Q2	$2.65M	Buy	+67,545	New	+$2.63M	1.44%	25

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Michael B. Elefante's TEVA Position: Q4 2014 in Review

Michael B. Elefante sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2014, closing a stake of 3,000 shares — an estimated $161K sold.

Michael B. Elefante first reported a position in TEVA in Q2 2013 and held it in 6 quarters. The position peaked at $2.65M in Q2 2013. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Michael B. Elefante reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2014 after selling out during the quarter.
Michael B. Elefante sold 3,000 Teva Pharmaceutical Industries Limited shares in Q4 2014, an estimated $161K.
Michael B. Elefante first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 6 quarters.
Michael B. Elefante's Teva Pharmaceutical Industries Limited position peaked at $2.65M in Q2 2013.
822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2014.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.